» Articles » PMID: 35140324

Blood-brain Barrier Disruption As a Cause of Various Serum Neuron-specific Enolase Cut-off Values for Neurological Prognosis in Cardiac Arrest Patients

Overview
Journal Sci Rep
Specialty Science
Date 2022 Feb 10
PMID 35140324
Authors
Affiliations
Soon will be listed here.
Abstract

We compared the cut-off and prognostic value of serum neuron-specific enolase (NSE) between groups with and without severe blood-brain barrier (BBB) disruption to reveal that a cause of various serum NSE cut-off value for neurological prognosis is severe BBB disruption in out-of-hospital cardiac arrest (OHCA) patients underwent target temperature management (TTM). This was a prospective, single-centre study conducted from January 2019 to June 2021. Severe BBB disruption was indicated using cerebrospinal fluid-serum albumin quotient values > 0.02. The area under the receiver operating characteristic curve of serum NSE obtained on day 3 of hospitalisation to predict poor outcomes was used. In patients with poor neurologic outcomes, serum NSE in those with severe BBB disruption was higher than in those without (P = 0.006). A serum NSE cut-off value of 40.4 μg/L for poor outcomes in patients without severe BBB disruption had a sensitivity of 41.7% and a specificity of 96.0%, whereas a cut-off value of 34.6 μg/L in those with severe BBB disruption had a sensitivity of 86.4% and a specificity of 100.0%. We demonstrated that the cut-off and prognostic value of serum NSE were heterogeneous, depending on severe BBB disruption in OHCA patients treated with TTM.

Citing Articles

Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO.

Hong S, De Souza B, Penberthy K, Hwang L, Procaccini D, Kheir J Neurotherapeutics. 2025; 22(1):e00521.

PMID: 39765416 PMC: 11840354. DOI: 10.1016/j.neurot.2024.e00521.


The Role of Systemic Inflammation in the Pathogenesis of Spontaneous Intracranial Hemorrhage in the Presence or Absence of Effective Cerebral Blood Flow.

Gusev E, Solomatina L, Bochkarev P, Zudova A, Chereshnev V J Clin Med. 2024; 13(15).

PMID: 39124721 PMC: 11313124. DOI: 10.3390/jcm13154454.


Validation of neuron-specific enolase in cardiac arrest patients with limited withdrawal of life-sustaining therapy.

Lee D, Lee B, Cho Y, Kim D, Ryu S, Min J Heliyon. 2024; 10(14):e34618.

PMID: 39113971 PMC: 11305282. DOI: 10.1016/j.heliyon.2024.e34618.


Carbon monoxide-releasing molecule-3 exerts neuroprotection effects after cardiac arrest in mice: A randomized controlled study.

Zhao Y, Yao Z, Lu L, Xu S, Sun J, Zhu Y Resusc Plus. 2024; 19:100703.

PMID: 39040821 PMC: 11260602. DOI: 10.1016/j.resplu.2024.100703.


Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflight.

Houerbi N, Kim J, Overbey E, Batra R, Schweickart A, Patras L Nat Commun. 2024; 15(1):4862.

PMID: 38862464 PMC: 11166969. DOI: 10.1038/s41467-024-48841-w.


References
1.
Daubin C, Quentin C, Allouche S, Etard O, Gaillard C, Seguin A . Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study. BMC Cardiovasc Disord. 2011; 11:48. PMC: 3161948. DOI: 10.1186/1471-2261-11-48. View

2.
Hasslacher J, Lehner G, Harler U, Beer R, Ulmer H, Kirchmair R . Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation. Intensive Care Med. 2014; 40(10):1518-27. DOI: 10.1007/s00134-014-3423-4. View

3.
Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M . Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017; 8:111-126. PMC: 5454085. DOI: 10.1016/j.dadm.2017.04.007. View

4.
Steffen I, Hasper D, Ploner C, Schefold J, Dietz E, Martens F . Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care. 2010; 14(2):R69. PMC: 2887191. DOI: 10.1186/cc8975. View

5.
Mlynash M, Buckwalter M, Okada A, Finley Caulfield A, Venkatasubramanian C, Eyngorn I . Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort. Neurocrit Care. 2013; 19(2):161-6. DOI: 10.1007/s12028-013-9867-5. View